

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alanine transport (GO:0032328) | 4.77257808 |
| 2 | low-density lipoprotein particle remodeling (GO:0034374) | 4.51410222 |
| 3 | extracellular matrix assembly (GO:0085029) | 4.45045810 |
| 4 | cellular response to cholesterol (GO:0071397) | 4.23483471 |
| 5 | negative regulation of astrocyte differentiation (GO:0048712) | 4.17807761 |
| 6 | C4-dicarboxylate transport (GO:0015740) | 4.12372305 |
| 7 | protein heterotrimerization (GO:0070208) | 4.07449474 |
| 8 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.98702228 |
| 9 | L-amino acid import (GO:0043092) | 3.97427889 |
| 10 | amino acid import (GO:0043090) | 3.85988821 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82386327 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 3.80822665 |
| 13 | collagen fibril organization (GO:0030199) | 3.73089734 |
| 14 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.71536168 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.67135793 |
| 16 | L-serine transport (GO:0015825) | 3.66868150 |
| 17 | extracellular fibril organization (GO:0043206) | 3.66449174 |
| 18 | sodium ion export (GO:0071436) | 3.66247493 |
| 19 | cellular response to sterol (GO:0036315) | 3.65720902 |
| 20 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.65035438 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 3.56344498 |
| 22 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.53957087 |
| 23 | axon extension involved in axon guidance (GO:0048846) | 3.53957087 |
| 24 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.53563397 |
| 25 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.52036844 |
| 26 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.51522677 |
| 27 | reverse cholesterol transport (GO:0043691) | 3.51202808 |
| 28 | cell migration involved in heart development (GO:0060973) | 3.50333727 |
| 29 | cell communication by electrical coupling (GO:0010644) | 3.39158098 |
| 30 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.38712493 |
| 31 | glomerular basement membrane development (GO:0032836) | 3.36214753 |
| 32 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.32810326 |
| 33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.30787549 |
| 34 | type B pancreatic cell proliferation (GO:0044342) | 3.28717025 |
| 35 | chondroitin sulfate catabolic process (GO:0030207) | 3.28603642 |
| 36 | chondrocyte proliferation (GO:0035988) | 3.27244492 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 3.26783821 |
| 38 | central nervous system myelination (GO:0022010) | 3.26783821 |
| 39 | adhesion of symbiont to host cell (GO:0044650) | 3.26247101 |
| 40 | virion attachment to host cell (GO:0019062) | 3.26247101 |
| 41 | negative regulation of sodium ion transport (GO:0010766) | 3.23431710 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 3.20034564 |
| 43 | cellular sodium ion homeostasis (GO:0006883) | 3.18600829 |
| 44 | cell proliferation involved in metanephros development (GO:0072203) | 3.17481477 |
| 45 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.16360507 |
| 46 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.13174292 |
| 47 | serine transport (GO:0032329) | 3.10489026 |
| 48 | fibril organization (GO:0097435) | 3.10457882 |
| 49 | regulation of beta-amyloid formation (GO:1902003) | 3.10148715 |
| 50 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09498612 |
| 51 | potassium ion import (GO:0010107) | 3.09095839 |
| 52 | regulation of astrocyte differentiation (GO:0048710) | 3.06809524 |
| 53 | endodermal cell differentiation (GO:0035987) | 3.05975265 |
| 54 | linoleic acid metabolic process (GO:0043651) | 3.04047351 |
| 55 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.03901058 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 3.03269408 |
| 57 | macromolecular complex remodeling (GO:0034367) | 3.03269408 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03269408 |
| 59 | cGMP-mediated signaling (GO:0019934) | 3.02032656 |
| 60 | dermatan sulfate biosynthetic process (GO:0030208) | 3.00427841 |
| 61 | keratan sulfate catabolic process (GO:0042340) | 2.98520990 |
| 62 | glial cell proliferation (GO:0014009) | 2.98327595 |
| 63 | dermatan sulfate metabolic process (GO:0030205) | 2.93082106 |
| 64 | response to auditory stimulus (GO:0010996) | 2.92972973 |
| 65 | negative regulation of protein localization to cell surface (GO:2000009) | 2.89979754 |
| 66 | collagen metabolic process (GO:0032963) | 2.87544905 |
| 67 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.87140247 |
| 68 | metanephric mesenchyme development (GO:0072075) | 2.85793539 |
| 69 | locomotory exploration behavior (GO:0035641) | 2.84192523 |
| 70 | sterol catabolic process (GO:0016127) | 2.82600950 |
| 71 | cholesterol catabolic process (GO:0006707) | 2.82600950 |
| 72 | myelination in peripheral nervous system (GO:0022011) | 2.82027827 |
| 73 | peripheral nervous system axon ensheathment (GO:0032292) | 2.82027827 |
| 74 | adhesion of symbiont to host (GO:0044406) | 2.80867796 |
| 75 | blood vessel maturation (GO:0001955) | 2.78379105 |
| 76 | ovulation cycle (GO:0042698) | 2.77805949 |
| 77 | postsynaptic membrane organization (GO:0001941) | 2.77409520 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 2.76732034 |
| 79 | bone trabecula formation (GO:0060346) | 2.75695977 |
| 80 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.75029885 |
| 81 | collagen catabolic process (GO:0030574) | 2.73559133 |
| 82 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.73054970 |
| 83 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.72383152 |
| 84 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.72332523 |
| 85 | skin morphogenesis (GO:0043589) | 2.71787969 |
| 86 | kidney mesenchyme development (GO:0072074) | 2.70733835 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.70057612 |
| 88 | barbed-end actin filament capping (GO:0051016) | 2.66296976 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 2.65351007 |
| 90 | atrial cardiac muscle cell action potential (GO:0086014) | 2.65133910 |
| 91 | high-density lipoprotein particle remodeling (GO:0034375) | 2.65113967 |
| 92 | adenine nucleotide transport (GO:0051503) | 2.61173233 |
| 93 | multicellular organismal metabolic process (GO:0044236) | 2.61021406 |
| 94 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.60862061 |
| 95 | very long-chain fatty acid metabolic process (GO:0000038) | 2.60587264 |
| 96 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.59857410 |
| 97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59710140 |
| 98 | purine nucleotide transport (GO:0015865) | 2.58632341 |
| 99 | apoptotic cell clearance (GO:0043277) | 2.56512629 |
| 100 | glutamate metabolic process (GO:0006536) | 2.55123872 |
| 101 | neurotransmitter uptake (GO:0001504) | 2.54917750 |
| 102 | multicellular organismal catabolic process (GO:0044243) | 2.54626938 |
| 103 | response to cholesterol (GO:0070723) | 2.54260875 |
| 104 | extracellular matrix organization (GO:0030198) | 2.53760036 |
| 105 | extracellular matrix disassembly (GO:0022617) | 2.53258324 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 2.53176750 |
| 107 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.52909962 |
| 108 | cell proliferation involved in kidney development (GO:0072111) | 2.52748264 |
| 109 | extracellular structure organization (GO:0043062) | 2.52670691 |
| 110 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.51648502 |
| 111 | protein-lipid complex subunit organization (GO:0071825) | 2.50159981 |
| 112 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.47955285 |
| 113 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.47578812 |
| 114 | potassium ion homeostasis (GO:0055075) | 2.46849681 |
| 115 | acidic amino acid transport (GO:0015800) | 2.46379778 |
| 116 | negative regulation of glial cell differentiation (GO:0045686) | 2.45788660 |
| 117 | oligodendrocyte differentiation (GO:0048709) | 2.44572873 |
| 118 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44482030 |
| 119 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.44225770 |
| 120 | venous blood vessel morphogenesis (GO:0048845) | 2.43924168 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.43644157 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42821815 |
| 123 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.42222723 |
| 124 | metanephric nephron tubule development (GO:0072234) | 2.39728844 |
| 125 | metanephric tubule development (GO:0072170) | 2.39728844 |
| 126 | regulation of plasminogen activation (GO:0010755) | 2.39619934 |
| 127 | endothelial cell morphogenesis (GO:0001886) | 2.39408958 |
| 128 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.39239228 |
| 129 | basement membrane organization (GO:0071711) | 2.39193940 |
| 130 | negative regulation of osteoblast proliferation (GO:0033689) | 2.38172774 |
| 131 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.37407502 |
| 132 | dicarboxylic acid catabolic process (GO:0043649) | 2.36783407 |
| 133 | plasma lipoprotein particle assembly (GO:0034377) | 2.36342049 |
| 134 | response to sterol (GO:0036314) | 2.36150730 |
| 135 | presynaptic membrane assembly (GO:0097105) | 2.35623294 |
| 136 | astrocyte differentiation (GO:0048708) | 2.35513202 |
| 137 | tooth mineralization (GO:0034505) | 2.35430616 |
| 138 | outer ear morphogenesis (GO:0042473) | 2.33596427 |
| 139 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.32115895 |
| 140 | gap junction assembly (GO:0016264) | 2.31847937 |
| 141 | lymphangiogenesis (GO:0001946) | 2.31271393 |
| 142 | auditory behavior (GO:0031223) | 2.31030568 |
| 143 | smooth muscle tissue development (GO:0048745) | 2.30196649 |
| 144 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28270766 |
| 145 | cellular response to vitamin (GO:0071295) | 2.27556311 |
| 146 | purine ribonucleotide transport (GO:0015868) | 2.27427399 |
| 147 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.26480991 |
| 148 | metanephric nephron epithelium development (GO:0072243) | 2.26175391 |
| 149 | cell differentiation involved in metanephros development (GO:0072202) | 2.25832368 |
| 150 | proline transport (GO:0015824) | 2.25519608 |
| 151 | short-chain fatty acid metabolic process (GO:0046459) | 2.25474385 |
| 152 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.25060288 |
| 153 | positive regulation of fatty acid oxidation (GO:0046321) | 2.24928433 |
| 154 | negative regulation of catenin import into nucleus (GO:0035414) | 2.24567940 |
| 155 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.24411655 |
| 156 | glycogen catabolic process (GO:0005980) | 2.24224702 |
| 157 | lens fiber cell development (GO:0070307) | 2.24087609 |
| 158 | amino-acid betaine metabolic process (GO:0006577) | 2.23831154 |
| 159 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.23743157 |
| 160 | L-serine metabolic process (GO:0006563) | 2.23088869 |
| 161 | positive regulation of extracellular matrix organization (GO:1903055) | 2.22997670 |
| 162 | radial glial cell differentiation (GO:0060019) | 2.22995095 |
| 163 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.22363141 |
| 164 | negative regulation of BMP signaling pathway (GO:0030514) | 2.22223299 |
| 165 | carnitine metabolic process (GO:0009437) | 2.22155000 |
| 166 | axon extension (GO:0048675) | 2.20862469 |
| 167 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.20827039 |
| 168 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.20685490 |
| 169 | regulation of cholesterol metabolic process (GO:0090181) | 2.20239247 |
| 170 | cerebellar granule cell differentiation (GO:0021707) | 2.20044277 |
| 171 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.19927769 |
| 172 | regulation of axon guidance (GO:1902667) | 2.19852242 |
| 173 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.17560648 |
| 174 | cardiac myofibril assembly (GO:0055003) | 2.17499628 |
| 175 | L-glutamate transport (GO:0015813) | 2.16892193 |
| 176 | protein localization to cell surface (GO:0034394) | 2.16320156 |
| 177 | camera-type eye morphogenesis (GO:0048593) | 2.15976286 |
| 178 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.15786021 |
| 179 | phospholipid efflux (GO:0033700) | 2.15458021 |
| 180 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.15323165 |
| 181 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.14422947 |
| 182 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.14104766 |
| 183 | cochlea morphogenesis (GO:0090103) | 2.13242421 |
| 184 | regulation of osteoblast proliferation (GO:0033688) | 2.12939107 |
| 185 | paraxial mesoderm development (GO:0048339) | 2.12176667 |
| 186 | vasculature development (GO:0001944) | 2.12118872 |
| 187 | glycosaminoglycan catabolic process (GO:0006027) | 2.11757063 |
| 188 | extracellular regulation of signal transduction (GO:1900115) | 2.10715748 |
| 189 | extracellular negative regulation of signal transduction (GO:1900116) | 2.10715748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.05589784 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70376100 |
| 3 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53966405 |
| 4 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45790767 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44917941 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.42637697 |
| 7 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34635440 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29911347 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29911347 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20837087 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18839627 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.17620690 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16678781 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16014135 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12124083 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09383347 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07197982 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99341434 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93848323 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93567545 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91071054 |
| 22 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.85612657 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85343729 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84905631 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81490089 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79533686 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75577151 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69031509 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.68276899 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67519699 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67383492 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55271277 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55185225 |
| 34 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54405079 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.54005454 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49692781 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43558149 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42339474 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41967833 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40620666 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40619554 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39659113 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35291257 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34552863 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33513922 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32946629 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32658520 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.32114381 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32011456 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30958154 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30542094 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27020384 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26463550 |
| 54 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25539973 |
| 55 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23044580 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22621470 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20191564 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18861262 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18861262 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18408708 |
| 61 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18042068 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18042068 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17983070 |
| 64 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17953723 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17635926 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16907158 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16509390 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14913977 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14497451 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13487114 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10614555 |
| 72 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.09918533 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09410255 |
| 74 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09225616 |
| 75 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08189113 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06265048 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06030890 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05063671 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03609467 |
| 80 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02622506 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01804730 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01469729 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01358262 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.01090990 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00828504 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00458055 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99441079 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98870280 |
| 89 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98780191 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98057671 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96115047 |
| 92 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95939711 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95099952 |
| 94 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93964110 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93526710 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93451389 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93127588 |
| 98 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.92362288 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92339073 |
| 100 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.91365120 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 0.91218963 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91047269 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90975881 |
| 104 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90909639 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90686450 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90649488 |
| 107 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90156705 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89862393 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89798239 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88447980 |
| 111 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.88332158 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88095437 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88027672 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87757592 |
| 115 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87692801 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87631799 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86321728 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86106980 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85846538 |
| 120 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84234737 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84152522 |
| 122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.82985383 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81918541 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81894891 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81779758 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81044228 |
| 127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77534183 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77515400 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77038026 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76887399 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.75671990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005275_abnormal_skin_tensile | 4.56465925 |
| 2 | MP0003690_abnormal_glial_cell | 3.62022010 |
| 3 | MP0004858_abnormal_nervous_system | 3.30179762 |
| 4 | MP0002254_reproductive_system_inflammat | 3.22074015 |
| 5 | MP0003329_amyloid_beta_deposits | 2.99530451 |
| 6 | MP0009384_cardiac_valve_regurgitation | 2.71518615 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.66231441 |
| 8 | MP0006054_spinal_hemorrhage | 2.65125055 |
| 9 | MP0009840_abnormal_foam_cell | 2.59298455 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.50718993 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.42037656 |
| 12 | MP0003279_aneurysm | 2.37796501 |
| 13 | MP0004885_abnormal_endolymph | 2.34357448 |
| 14 | MP0003136_yellow_coat_color | 2.30411305 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.20830865 |
| 16 | MP0005360_urolithiasis | 2.08837489 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.02148694 |
| 18 | MP0000604_amyloidosis | 1.92178064 |
| 19 | MP0003075_altered_response_to | 1.90318177 |
| 20 | MP0005332_abnormal_amino_acid | 1.85267626 |
| 21 | MP0010030_abnormal_orbit_morphology | 1.84124111 |
| 22 | MP0003011_delayed_dark_adaptation | 1.79952814 |
| 23 | MP0002108_abnormal_muscle_morphology | 1.79762224 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.79212284 |
| 25 | MP0001486_abnormal_startle_reflex | 1.77792345 |
| 26 | MP0005365_abnormal_bile_salt | 1.73431989 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.64089871 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.57682963 |
| 29 | MP0005171_absent_coat_pigmentation | 1.56111583 |
| 30 | MP0003634_abnormal_glial_cell | 1.55829495 |
| 31 | MP0000767_abnormal_smooth_muscle | 1.55410074 |
| 32 | MP0004270_analgesia | 1.54903857 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.53776794 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.52836518 |
| 35 | MP0000566_synostosis | 1.52468514 |
| 36 | MP0001542_abnormal_bone_strength | 1.50984966 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.49956716 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48041591 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.43363622 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.37775834 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.37185721 |
| 42 | MP0003878_abnormal_ear_physiology | 1.37185721 |
| 43 | MP0002896_abnormal_bone_mineralization | 1.36356950 |
| 44 | MP0005023_abnormal_wound_healing | 1.35951324 |
| 45 | MP0003091_abnormal_cell_migration | 1.34503500 |
| 46 | MP0002060_abnormal_skin_morphology | 1.34491068 |
| 47 | MP0002064_seizures | 1.32888223 |
| 48 | MP0003633_abnormal_nervous_system | 1.32525787 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.31758637 |
| 50 | MP0000534_abnormal_ureter_morphology | 1.31729290 |
| 51 | MP0004130_abnormal_muscle_cell | 1.31713470 |
| 52 | MP0001958_emphysema | 1.31586298 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.31210330 |
| 54 | MP0002090_abnormal_vision | 1.28955664 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.28530973 |
| 56 | MP0009745_abnormal_behavioral_response | 1.28127140 |
| 57 | MP0009046_muscle_twitch | 1.26111821 |
| 58 | MP0005595_abnormal_vascular_smooth | 1.25767686 |
| 59 | MP0005670_abnormal_white_adipose | 1.24282777 |
| 60 | MP0004272_abnormal_basement_membrane | 1.22805177 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.20536054 |
| 62 | MP0000681_abnormal_thyroid_gland | 1.19929393 |
| 63 | MP0000428_abnormal_craniofacial_morphol | 1.18469797 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.17421622 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.15427004 |
| 66 | MP0000920_abnormal_myelination | 1.14633352 |
| 67 | MP0002295_abnormal_pulmonary_circulatio | 1.14088073 |
| 68 | MP0003632_abnormal_nervous_system | 1.13382033 |
| 69 | MP0002133_abnormal_respiratory_system | 1.13126716 |
| 70 | MP0005388_respiratory_system_phenotype | 1.13126716 |
| 71 | MP0003631_nervous_system_phenotype | 1.12590433 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 1.09738410 |
| 73 | MP0001853_heart_inflammation | 1.09669584 |
| 74 | MP0008569_lethality_at_weaning | 1.08899164 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.08687612 |
| 76 | MP0002249_abnormal_larynx_morphology | 1.08572300 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.08243655 |
| 78 | MP0003941_abnormal_skin_development | 1.05998916 |
| 79 | MP0005165_increased_susceptibility_to | 1.03606524 |
| 80 | MP0001243_abnormal_dermal_layer | 1.02447062 |
| 81 | MP0001984_abnormal_olfaction | 1.02043927 |
| 82 | MP0003942_abnormal_urinary_system | 1.01435393 |
| 83 | MP0000163_abnormal_cartilage_morphology | 1.00221919 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.00057674 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.99808409 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.99184885 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.98795907 |
| 88 | MP0000751_myopathy | 0.97542984 |
| 89 | MP0005647_abnormal_sex_gland | 0.96571150 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.93764301 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.91065057 |
| 92 | MP0005390_skeleton_phenotype | 0.90221746 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.90188701 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.89851149 |
| 95 | MP0002272_abnormal_nervous_system | 0.88741300 |
| 96 | MP0000778_abnormal_nervous_system | 0.88702651 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87748705 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.86573553 |
| 99 | MP0000049_abnormal_middle_ear | 0.85702162 |
| 100 | MP0003115_abnormal_respiratory_system | 0.84563909 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.83583993 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.82828380 |
| 103 | MP0002557_abnormal_social/conspecific_i | 0.82772176 |
| 104 | MP0002115_abnormal_skeleton_extremities | 0.82572738 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 0.82466120 |
| 106 | MP0003880_abnormal_central_pattern | 0.81930345 |
| 107 | MP0000762_abnormal_tongue_morphology | 0.81641361 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.81344573 |
| 109 | MP0002971_abnormal_brown_adipose | 0.81047647 |
| 110 | MP0001177_atelectasis | 0.80115493 |
| 111 | MP0003252_abnormal_bile_duct | 0.79180132 |
| 112 | MP0005166_decreased_susceptibility_to | 0.78784472 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.78778404 |
| 114 | MP0005164_abnormal_response_to | 0.78776071 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.77921701 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.77571726 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.77334026 |
| 118 | MP0006138_congestive_heart_failure | 0.76466902 |
| 119 | MP0004043_abnormal_pH_regulation | 0.76261033 |
| 120 | MP0002128_abnormal_blood_circulation | 0.75809427 |
| 121 | MP0002733_abnormal_thermal_nociception | 0.75680045 |
| 122 | MP0003385_abnormal_body_wall | 0.75469640 |
| 123 | MP0002972_abnormal_cardiac_muscle | 0.75231093 |
| 124 | MP0004019_abnormal_vitamin_homeostasis | 0.74116076 |
| 125 | MP0000749_muscle_degeneration | 0.73968896 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.73854180 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.72273760 |
| 128 | MP0000462_abnormal_digestive_system | 0.70721992 |
| 129 | MP0004883_abnormal_blood_vessel | 0.70152323 |
| 130 | MP0002736_abnormal_nociception_after | 0.70034282 |
| 131 | MP0002933_joint_inflammation | 0.69929006 |
| 132 | MP0000343_altered_response_to | 0.69740594 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.69466004 |
| 134 | MP0001915_intracranial_hemorrhage | 0.69456694 |
| 135 | MP0000026_abnormal_inner_ear | 0.69250600 |
| 136 | MP0009053_abnormal_anal_canal | 0.69143273 |
| 137 | MP0005508_abnormal_skeleton_morphology | 0.69035573 |
| 138 | MP0002998_abnormal_bone_remodeling | 0.68724627 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.67908682 |
| 140 | MP0001614_abnormal_blood_vessel | 0.66530615 |
| 141 | MP0004084_abnormal_cardiac_muscle | 0.65797980 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.64431650 |
| 143 | MP0000432_abnormal_head_morphology | 0.63137851 |
| 144 | MP0003879_abnormal_hair_cell | 0.63001041 |
| 145 | MP0003755_abnormal_palate_morphology | 0.62670584 |
| 146 | MP0002116_abnormal_craniofacial_bone | 0.62524172 |
| 147 | MP0000733_abnormal_muscle_development | 0.59783730 |
| 148 | MP0001849_ear_inflammation | 0.59481515 |
| 149 | MP0001175_abnormal_lung_morphology | 0.58615449 |
| 150 | MP0002113_abnormal_skeleton_development | 0.57594395 |
| 151 | MP0005369_muscle_phenotype | 0.57067958 |
| 152 | MP0000003_abnormal_adipose_tissue | 0.55817178 |
| 153 | MP0005197_abnormal_uvea_morphology | 0.55607246 |
| 154 | MP0002932_abnormal_joint_morphology | 0.53835763 |
| 155 | MP0003283_abnormal_digestive_organ | 0.53761970 |
| 156 | MP0005193_abnormal_anterior_eye | 0.53721511 |
| 157 | MP0001270_distended_abdomen | 0.52566981 |
| 158 | MP0002092_abnormal_eye_morphology | 0.52242095 |
| 159 | MP0000747_muscle_weakness | 0.51241517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.85950234 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 5.85950234 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 5.85950234 |
| 4 | Premature rupture of membranes (HP:0001788) | 5.62396237 |
| 5 | Megalencephaly (HP:0001355) | 5.45253339 |
| 6 | Neurofibrillary tangles (HP:0002185) | 5.10865639 |
| 7 | Vascular tortuosity (HP:0004948) | 4.92141805 |
| 8 | Aortic aneurysm (HP:0004942) | 4.84362664 |
| 9 | Aortic dissection (HP:0002647) | 4.39787603 |
| 10 | Arterial tortuosity (HP:0005116) | 4.15995167 |
| 11 | Ankle contracture (HP:0006466) | 4.13121884 |
| 12 | Follicular hyperkeratosis (HP:0007502) | 4.02106449 |
| 13 | Soft skin (HP:0000977) | 3.83855031 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.81830287 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.80653728 |
| 16 | Bladder diverticulum (HP:0000015) | 3.68655221 |
| 17 | Synostosis involving the elbow (HP:0003938) | 3.61712408 |
| 18 | Humeroradial synostosis (HP:0003041) | 3.61712408 |
| 19 | Hemiplegia (HP:0002301) | 3.60494908 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.56285840 |
| 21 | Hemiparesis (HP:0001269) | 3.52607177 |
| 22 | Xanthomatosis (HP:0000991) | 3.46308425 |
| 23 | Wormian bones (HP:0002645) | 3.42919568 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.34586711 |
| 25 | Spinal rigidity (HP:0003306) | 3.33175751 |
| 26 | Hyperglycinuria (HP:0003108) | 3.33039121 |
| 27 | Abnormality of secondary sexual hair (HP:0009888) | 3.32471486 |
| 28 | Abnormality of the axillary hair (HP:0100134) | 3.32471486 |
| 29 | Cervical subluxation (HP:0003308) | 3.30503859 |
| 30 | Diplopia (HP:0000651) | 3.28978576 |
| 31 | Abnormality of binocular vision (HP:0011514) | 3.28978576 |
| 32 | Vertebral compression fractures (HP:0002953) | 3.22925377 |
| 33 | Hypoplastic left heart (HP:0004383) | 3.18401523 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.13413641 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.13413641 |
| 36 | Back pain (HP:0003418) | 3.13385725 |
| 37 | Short hallux (HP:0010109) | 3.11336635 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.96894852 |
| 39 | Clumsiness (HP:0002312) | 2.92556687 |
| 40 | Slender build (HP:0001533) | 2.92270244 |
| 41 | Abnormality of dentin (HP:0010299) | 2.88763061 |
| 42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.83303237 |
| 43 | Osteolytic defects of the hand bones (HP:0009699) | 2.83303237 |
| 44 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.82566740 |
| 45 | Amyloidosis (HP:0011034) | 2.78491486 |
| 46 | Dilatation of the ascending aorta (HP:0005111) | 2.75267106 |
| 47 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.71430221 |
| 48 | Coronal craniosynostosis (HP:0004440) | 2.70953893 |
| 49 | Pulmonary artery stenosis (HP:0004415) | 2.70064382 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.68928864 |
| 51 | Ketoacidosis (HP:0001993) | 2.68311592 |
| 52 | Aortic regurgitation (HP:0001659) | 2.61599526 |
| 53 | Hyperextensible skin (HP:0000974) | 2.59760550 |
| 54 | Complement deficiency (HP:0004431) | 2.56445010 |
| 55 | Wide anterior fontanel (HP:0000260) | 2.55268150 |
| 56 | Mitral regurgitation (HP:0001653) | 2.54615648 |
| 57 | Broad metatarsal (HP:0001783) | 2.53528513 |
| 58 | Biconcave vertebral bodies (HP:0004586) | 2.53419187 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.52783908 |
| 60 | Adactyly (HP:0009776) | 2.50956167 |
| 61 | Ketosis (HP:0001946) | 2.49393085 |
| 62 | Atrophic scars (HP:0001075) | 2.48059762 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.47957178 |
| 64 | Mitral stenosis (HP:0001718) | 2.47641939 |
| 65 | Neonatal short-limb short stature (HP:0008921) | 2.47423749 |
| 66 | Confusion (HP:0001289) | 2.46123652 |
| 67 | Bronchomalacia (HP:0002780) | 2.45804888 |
| 68 | Abnormality of complement system (HP:0005339) | 2.45399867 |
| 69 | Blue sclerae (HP:0000592) | 2.44729108 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44548102 |
| 71 | Joint laxity (HP:0001388) | 2.43677612 |
| 72 | Aortic valve stenosis (HP:0001650) | 2.43050817 |
| 73 | Potter facies (HP:0002009) | 2.42227033 |
| 74 | Facial shape deformation (HP:0011334) | 2.42227033 |
| 75 | Split foot (HP:0001839) | 2.41566411 |
| 76 | Hyperglycinemia (HP:0002154) | 2.39810864 |
| 77 | Bowel diverticulosis (HP:0005222) | 2.36843363 |
| 78 | Camptodactyly of toe (HP:0001836) | 2.35075202 |
| 79 | Genu recurvatum (HP:0002816) | 2.34772569 |
| 80 | Fragile skin (HP:0001030) | 2.32512962 |
| 81 | Hypoplasia of the iris (HP:0007676) | 2.31733055 |
| 82 | Hypoplastic heart (HP:0001961) | 2.30998608 |
| 83 | Mixed hearing impairment (HP:0000410) | 2.30743821 |
| 84 | Status epilepticus (HP:0002133) | 2.30682332 |
| 85 | Hypolipoproteinemia (HP:0010981) | 2.28685275 |
| 86 | Tetraparesis (HP:0002273) | 2.28537461 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.28014344 |
| 88 | Pseudobulbar signs (HP:0002200) | 2.26402578 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.24017784 |
| 90 | Turricephaly (HP:0000262) | 2.23787733 |
| 91 | Hypoventilation (HP:0002791) | 2.22288578 |
| 92 | Supranuclear gaze palsy (HP:0000605) | 2.22247260 |
| 93 | Mitral valve prolapse (HP:0001634) | 2.21531821 |
| 94 | Spondylolisthesis (HP:0003302) | 2.20042529 |
| 95 | Aneurysm (HP:0002617) | 2.19899014 |
| 96 | Mesangial abnormality (HP:0001966) | 2.19185313 |
| 97 | Absent hair (HP:0002298) | 2.15795728 |
| 98 | Hyperammonemia (HP:0001987) | 2.15044853 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.14175429 |
| 100 | Joint stiffness (HP:0001387) | 2.13008398 |
| 101 | Paraparesis (HP:0002385) | 2.06653757 |
| 102 | Narrow nasal bridge (HP:0000446) | 2.05821087 |
| 103 | Peritonitis (HP:0002586) | 2.05135070 |
| 104 | Long nose (HP:0003189) | 2.03552694 |
| 105 | Increased connective tissue (HP:0009025) | 2.03542198 |
| 106 | Partial duplication of the phalanx of hand (HP:0009999) | 2.03424489 |
| 107 | Wrist flexion contracture (HP:0001239) | 2.03406536 |
| 108 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00411299 |
| 109 | Onycholysis (HP:0001806) | 1.98328552 |
| 110 | Prolonged partial thromboplastin time (HP:0003645) | 1.97335183 |
| 111 | Ectopia lentis (HP:0001083) | 1.97235568 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96600719 |
| 113 | Absent toe (HP:0010760) | 1.96476310 |
| 114 | Fibular aplasia (HP:0002990) | 1.95700227 |
| 115 | Limited hip movement (HP:0008800) | 1.93961310 |
| 116 | Atrioventricular block (HP:0001678) | 1.93740203 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.91039766 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.91039766 |
| 119 | Action tremor (HP:0002345) | 1.88829659 |
| 120 | Abnormality of the dental pulp (HP:0006479) | 1.88182646 |
| 121 | Myokymia (HP:0002411) | 1.86778248 |
| 122 | Striae distensae (HP:0001065) | 1.86710359 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 1.86583234 |
| 124 | Large for gestational age (HP:0001520) | 1.86053198 |
| 125 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.85569876 |
| 126 | Partial duplication of thumb phalanx (HP:0009944) | 1.81285473 |
| 127 | Round ear (HP:0100830) | 1.79588335 |
| 128 | Ovoid vertebral bodies (HP:0003300) | 1.79560582 |
| 129 | Tetraplegia (HP:0002445) | 1.79325216 |
| 130 | Abnormality of the anterior chamber (HP:0000593) | 1.79306971 |
| 131 | Abnormal delivery (HP:0001787) | 1.78038617 |
| 132 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.77743110 |
| 133 | Osteoarthritis (HP:0002758) | 1.77615430 |
| 134 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.76783684 |
| 135 | Ulnar bowing (HP:0003031) | 1.75808454 |
| 136 | Tarsal synostosis (HP:0008368) | 1.74561551 |
| 137 | Flat cornea (HP:0007720) | 1.73929602 |
| 138 | Abnormality of the acetabulum (HP:0003170) | 1.73560383 |
| 139 | Broad ribs (HP:0000885) | 1.73519943 |
| 140 | Short middle phalanx of the 5th finger (HP:0004220) | 1.73279670 |
| 141 | Exercise-induced myalgia (HP:0003738) | 1.72630568 |
| 142 | Abnormality of the diencephalon (HP:0010662) | 1.71773762 |
| 143 | Abnormality of nail color (HP:0100643) | 1.71665067 |
| 144 | Joint contractures involving the joints of the feet (HP:0100492) | 1.71374712 |
| 145 | Flexion contracture of toe (HP:0005830) | 1.71374712 |
| 146 | Delayed cranial suture closure (HP:0000270) | 1.71298035 |
| 147 | Epidermoid cyst (HP:0200040) | 1.70988169 |
| 148 | Keratoconus (HP:0000563) | 1.70977601 |
| 149 | Increased corneal curvature (HP:0100692) | 1.70977601 |
| 150 | Protrusio acetabuli (HP:0003179) | 1.70463373 |
| 151 | Polygenic inheritance (HP:0010982) | 1.70381797 |
| 152 | Elbow flexion contracture (HP:0002987) | 1.69854682 |
| 153 | Gingival overgrowth (HP:0000212) | 1.68937078 |
| 154 | Epileptic encephalopathy (HP:0200134) | 1.68926879 |
| 155 | Spastic paraparesis (HP:0002313) | 1.68344543 |
| 156 | Intention tremor (HP:0002080) | 1.68015773 |
| 157 | Limb-girdle muscle weakness (HP:0003325) | 1.68010006 |
| 158 | Abnormal eating behavior (HP:0100738) | 1.67650472 |
| 159 | Mild short stature (HP:0003502) | 1.66497546 |
| 160 | Protruding ear (HP:0000411) | 1.66133288 |
| 161 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.65950115 |
| 162 | Dysdiadochokinesis (HP:0002075) | 1.65733768 |
| 163 | Hypercholesterolemia (HP:0003124) | 1.64178584 |
| 164 | Venous insufficiency (HP:0005293) | 1.64069858 |
| 165 | Flared iliac wings (HP:0002869) | 1.63937315 |
| 166 | Skin nodule (HP:0200036) | 1.63332810 |
| 167 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.63213498 |
| 168 | Synostosis involving bones of the feet (HP:0009140) | 1.63213498 |
| 169 | Multifactorial inheritance (HP:0001426) | 1.62746479 |
| 170 | Hypoglycemic coma (HP:0001325) | 1.62246179 |
| 171 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.62162108 |
| 172 | Inguinal hernia (HP:0000023) | 1.61856049 |
| 173 | Shallow orbits (HP:0000586) | 1.60898673 |
| 174 | Maternal diabetes (HP:0009800) | 1.60778493 |
| 175 | Stroke (HP:0001297) | 1.60306199 |
| 176 | Infantile muscular hypotonia (HP:0008947) | 1.60166305 |
| 177 | Overgrowth (HP:0001548) | 1.60057799 |
| 178 | Cardiovascular calcification (HP:0011915) | 1.59205593 |
| 179 | Polyphagia (HP:0002591) | 1.59096574 |
| 180 | Generalized amyotrophy (HP:0003700) | 1.58967895 |
| 181 | Deviation of the hallux (HP:0010051) | 1.58740791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.50254610 |
| 2 | LMTK2 | 4.38499086 |
| 3 | PHKG1 | 3.31763021 |
| 4 | PHKG2 | 3.31763021 |
| 5 | SIK1 | 3.13564286 |
| 6 | NTRK2 | 3.03411440 |
| 7 | PRKD3 | 2.94034821 |
| 8 | TNIK | 2.78827296 |
| 9 | NEK9 | 2.78251873 |
| 10 | TRIB3 | 2.68738727 |
| 11 | MYLK | 2.58325494 |
| 12 | EPHA3 | 2.09758327 |
| 13 | MAPK15 | 1.81032673 |
| 14 | GRK5 | 1.74170520 |
| 15 | PAK2 | 1.68146807 |
| 16 | MUSK | 1.67191244 |
| 17 | DDR2 | 1.65540808 |
| 18 | BCKDK | 1.62629462 |
| 19 | TIE1 | 1.60987426 |
| 20 | MOS | 1.56328630 |
| 21 | LIMK1 | 1.48599806 |
| 22 | PDGFRB | 1.46503820 |
| 23 | BRSK2 | 1.45367631 |
| 24 | AKT3 | 1.44086862 |
| 25 | MAPK12 | 1.43965894 |
| 26 | TTN | 1.43400731 |
| 27 | NTRK3 | 1.42479594 |
| 28 | PNCK | 1.39455554 |
| 29 | FGFR2 | 1.35150409 |
| 30 | PDGFRA | 1.34869368 |
| 31 | PTK2 | 1.34438546 |
| 32 | SGK494 | 1.31876738 |
| 33 | SGK223 | 1.31876738 |
| 34 | SGK2 | 1.29841944 |
| 35 | ERN1 | 1.27943183 |
| 36 | NTRK1 | 1.21725748 |
| 37 | SGK3 | 1.14658701 |
| 38 | EPHB1 | 1.12220881 |
| 39 | PINK1 | 1.11383087 |
| 40 | CASK | 1.10765810 |
| 41 | TYRO3 | 1.10056025 |
| 42 | TESK1 | 1.08233769 |
| 43 | ABL2 | 1.07986026 |
| 44 | PAK3 | 1.06654465 |
| 45 | INSRR | 1.06223680 |
| 46 | RIPK1 | 1.06124160 |
| 47 | WEE1 | 1.02557137 |
| 48 | PAK6 | 1.00963199 |
| 49 | EPHB2 | 1.00428855 |
| 50 | GRK1 | 0.99977112 |
| 51 | MAPK7 | 0.98156819 |
| 52 | MAPK13 | 0.94575310 |
| 53 | PRKCH | 0.94509508 |
| 54 | CAMK1G | 0.93476500 |
| 55 | FGR | 0.92813529 |
| 56 | BMX | 0.92496957 |
| 57 | MINK1 | 0.91116353 |
| 58 | PRKCG | 0.90896597 |
| 59 | ERBB4 | 0.90447646 |
| 60 | ROCK1 | 0.88696483 |
| 61 | DAPK2 | 0.87797358 |
| 62 | PRKCE | 0.85962753 |
| 63 | MAP3K6 | 0.85896143 |
| 64 | PAK4 | 0.84327802 |
| 65 | CDK5 | 0.82309422 |
| 66 | MARK1 | 0.81333997 |
| 67 | STK39 | 0.81275689 |
| 68 | CAMK1D | 0.79594275 |
| 69 | RPS6KA2 | 0.77141090 |
| 70 | CAMK2B | 0.76741758 |
| 71 | OXSR1 | 0.76425223 |
| 72 | KIT | 0.75456717 |
| 73 | DMPK | 0.74680014 |
| 74 | ADRBK1 | 0.74488426 |
| 75 | MAP3K13 | 0.74400904 |
| 76 | PRPF4B | 0.73765071 |
| 77 | PRKD2 | 0.73708841 |
| 78 | NEK6 | 0.72266208 |
| 79 | MAP3K7 | 0.71700366 |
| 80 | ICK | 0.71435284 |
| 81 | CAMK2A | 0.69715752 |
| 82 | ROCK2 | 0.67555831 |
| 83 | KDR | 0.67198565 |
| 84 | BRSK1 | 0.66617464 |
| 85 | LATS2 | 0.65540045 |
| 86 | JAK1 | 0.65396366 |
| 87 | MAP3K4 | 0.65268533 |
| 88 | KSR2 | 0.64898288 |
| 89 | PRKAA2 | 0.64604906 |
| 90 | GSK3A | 0.64143234 |
| 91 | MET | 0.64038362 |
| 92 | STK38 | 0.62871107 |
| 93 | MAP2K4 | 0.62607466 |
| 94 | WNK1 | 0.62489617 |
| 95 | GRK7 | 0.62395165 |
| 96 | CAMKK1 | 0.62362077 |
| 97 | STK38L | 0.62035273 |
| 98 | PTK6 | 0.61972857 |
| 99 | PRKD1 | 0.61711926 |
| 100 | CAMK2G | 0.61022567 |
| 101 | PDPK1 | 0.60082906 |
| 102 | CAMK2D | 0.60022239 |
| 103 | LATS1 | 0.59577476 |
| 104 | PTK2B | 0.58722161 |
| 105 | PDK2 | 0.58158981 |
| 106 | ADRBK2 | 0.57233642 |
| 107 | FGFR1 | 0.56664875 |
| 108 | UHMK1 | 0.56214337 |
| 109 | MAPK4 | 0.56111011 |
| 110 | PKN1 | 0.53740154 |
| 111 | FGFR3 | 0.53598724 |
| 112 | CDC42BPA | 0.53359277 |
| 113 | MARK2 | 0.52198917 |
| 114 | IGF1R | 0.51904964 |
| 115 | FGFR4 | 0.50446825 |
| 116 | MAP2K1 | 0.49100065 |
| 117 | MAP2K7 | 0.49037729 |
| 118 | PDK3 | 0.48924706 |
| 119 | PDK4 | 0.48924706 |
| 120 | PRKACG | 0.47865461 |
| 121 | SGK1 | 0.47651372 |
| 122 | DYRK1A | 0.47314821 |
| 123 | MAPKAPK5 | 0.45776932 |
| 124 | MAP3K9 | 0.44497049 |
| 125 | NLK | 0.44323397 |
| 126 | CAMK1 | 0.44056780 |
| 127 | PBK | 0.43799251 |
| 128 | FER | 0.43217006 |
| 129 | MTOR | 0.42867432 |
| 130 | PLK2 | 0.42518869 |
| 131 | SRC | 0.42461301 |
| 132 | DAPK3 | 0.42305129 |
| 133 | PRKCA | 0.41711887 |
| 134 | MELK | 0.40805538 |
| 135 | PRKCZ | 0.40794058 |
| 136 | PRKG1 | 0.40170825 |
| 137 | WNK4 | 0.39591089 |
| 138 | PRKCQ | 0.39229957 |
| 139 | RET | 0.39041757 |
| 140 | PRKACA | 0.39022568 |
| 141 | TGFBR2 | 0.38650029 |
| 142 | IRAK3 | 0.38253301 |
| 143 | ERBB2 | 0.37675012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.66424663 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.44942093 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.85586703 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77829204 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.66765255 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61609742 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15746811 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.12180714 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 2.01823600 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84349375 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81008089 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.77575645 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77185627 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70946656 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.58853579 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53390270 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44481156 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41433724 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40126815 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.39455720 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38039023 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36510092 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34706078 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33631414 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.31505869 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24874425 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24777573 |
| 28 | Amoebiasis_Homo sapiens_hsa05146 | 1.24479325 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23013291 |
| 30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17533568 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15552838 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15195181 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12569711 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12133823 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 1.08433411 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.07356652 |
| 37 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06519956 |
| 38 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.05595774 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02934157 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01328615 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00066947 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94130953 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94057113 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90452307 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89925087 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88885837 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86714570 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86532666 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85675896 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85495352 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85068148 |
| 52 | Melanoma_Homo sapiens_hsa05218 | 0.84648141 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84423798 |
| 54 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84254475 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84113385 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83427300 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.82827316 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81835963 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81601486 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81269609 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79727612 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79611684 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79058310 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77972556 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77747462 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77344646 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76909354 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75911262 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.72949534 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71434981 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68996253 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68581522 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68494905 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.67910029 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.67727453 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.66556196 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64683107 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64200962 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63648988 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63560499 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62909245 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62871076 |
| 83 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62169393 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.62054302 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61775952 |
| 86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61108440 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61083762 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59781795 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59672224 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59403210 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58618434 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58488989 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58140212 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57944217 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57924643 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57547452 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.56700797 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56645921 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56508493 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.55978208 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55838239 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55706236 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54740209 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.54718841 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53258135 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52520287 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52366529 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51939657 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51198328 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50935897 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50701196 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50128241 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49907887 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49719220 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49367257 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.49177591 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.48402043 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47401406 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46930791 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46859453 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.46768594 |
| 122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46696153 |
| 123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45367489 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44850911 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44717451 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.44678866 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44134158 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42790922 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42282078 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41166785 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40544132 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39954446 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39668619 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39434197 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39153135 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.38985169 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37815671 |
| 138 | Gap junction_Homo sapiens_hsa04540 | 0.36402840 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36220339 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35988778 |
| 141 | Axon guidance_Homo sapiens_hsa04360 | 0.35456165 |
| 142 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35162175 |

